For use

outside
the U.S.
only

Test Menu

ADVIA Centaur XPT/XP/CP

Immunoassay Systems
Siemens Healthineers unites innovative workflow solutions with clinical
excellence in the ADVIA Centaur® family of systems, leading to greater
laboratory productivity to stay ahead of increasing workload demands. ADVIA Centaur XPT System

• Drives reliable results with the sensitivity and specificity you expect of
chemiluminescence using Advanced Acridinium Ester Technology
• Simplifies laboratory operations even more with connection to
Siemens Healthineers automation* and IT solutions
• Standardizes within your network using the same ready-to-use reagents
across all ADVIA Centaur Systems

ADVIA Centaur XPT and XP Systems

ADVIA Centaur XP System
Engineered for continuous operation and timely, accurate results, the high-
performance ADVIA Centaur® XPT and XP Systems are always ready to stay
ahead of increasing workflow demands. Their extensive onboard reagent
capacities and dedicated STAT capabilities increase productivity, regardless
of volume or types of tests.

ADVIA Centaur CP System

The ADVIA Centaur® CP System is a mid-volume benchtop system that
enhances your in-house test capabilities. With its broad menu and short
turnaround times, you can do more—without compromising efficiency, ADVIA Centaur CP System
productivity, or quality.
*ADVIA Centaur XP/XPT Systems only
siemens-healthineers.com
ADVIA Centaur XPT/XP/CP Immunoassay Systems
Test Menu Hepatitis Metabolic Sepsis
♦ ADVIA Centaur XP/XPT Systems ♦ ● Anti-HBe ♦ ● Cortisol ♦ ● Procalcitonin (PCT)
● ADVIA Centaur CP System ♦ ● Anti-HBs 2 ♦ ● Homocysteine
Special ID
♦ ● HAV IgM
♦ ● HAV Total Neurology ♦* ●* EBV-EBNA IgG
Anemia ♦* ●* β-Amyloid 1-42 (AB42) ♦* ●* EBV-VCA IgG
♦ ● HBc IgM
♦ ● Active-B12 ♦ ● HBc Total ♦* ●* Total Tau (TTAU) ♦* ●* EBV-VCA IgM
♦ ● EPO ♦ ● HBc Total 2 ♦** SARS-CoV-2 Ag (CoVAg)
♦ ● Ferritin ♦ HBeAg Oncology ♦§ SARS-CoV-2 IgG (COV2G)
♦ ● Folate ♦ ● HBsAg Confirmatory ♦ ● AFP ♦** ●** SARS-CoV-2 IgG (sCOVG)
♦ ● RBC Folate ♦ ● HBsAg II ♦ BR 27.29 ♦§ SARS-CoV-2 Total (COV2T)
♦ ● Vitamin B12 ♦ HBsAg II Quant ♦† ●† CA 125II ♦ ● Syphilis
♦ ● HCV ♦‡ ●‡ Zika Test
♦† ●† CA 15-3
Autoimmune
♦† ●† CA 19-9
HIV Therapeutic Drug Monitoring
♦ ● Anti-CCP IgG ♦ ●* Calcitonin
♦ ● HIV 1/O/2 Enhanced (EHIV) (TDM)
Bone Metabolism ♦ ● CEA
♦ ● HIV Ag/Ab Combo (CHIV) ♦ ● Complexed PSA ♦ ● Carbamazepine
♦ ● Intact PTH ♦* ●* CYFRA 21-1 ♦ ● Digitoxin
♦ Vitamin D Total Immunosuppressant Drugs ♦ ● Digoxin
♦ Free PSA
♦ ● Cyclosporine ♦* ●* Neuron Specific ♦ ● Gentamicin
Cardiac ● Phenobarbital
♦* ●* Everolimus Enolase (NSE) ♦
♦ ● BNP ♦* ●* Sirolimus ♦ ● PSA ♦ ● Phenytoin
♦ ● CKMB ♦* ●* Tacrolimus ♦ ● Serum HER-2/neu ♦ ● Theophylline
♦ ● High-Sensitivity Troponin I ♦* ●* Squamous Cell ♦ ● Valproic Acid
♦ ● Myoglobin Inflammation ♦ ● Vancomycin
Carcinoma Antigen (SCC)
♦ ● NT-proBNP ♦ ● IgE Total
Reproductive Thyroid
♦ ● IL-6
Diabetes Endocrinology
♦ ● LBP ♦ ● aTgII
♦ ● C-Peptide ♦* ●* TNFα ♦ ● AFP ♦ ● Anti-TPO
♦ ● Insulin ♦ ● Androstenedione ♦ ● Free T3
Liver Fibrosis ♦* ●* Anti-Müllerian Hormone ♦ ● Free T4
♦ ● Enhanced Liver Fibrosis ♦ ● DHEA-SO4 ♦ ● Total T3
(ELF™) Test ♦ ● Enhanced Estradiol ♦ ● Total T4
♦ ● HA (ELF™ Marker) ♦ ● Free Beta HCG ♦ ● TSH3-Ultra
♦ ● PIIINP (ELF™ Marker) ♦ ● FSH ♦ ● TSH
♦ ● TIMP-1 (ELF™ Marker) ♦ ● hCG ●
♦ T Uptake
♦ ● LH
*Under development. Not commercially available. Future availability cannot ♦ ● PAPP-A TORCH
be guaranteed. ♦* ●* PIGF ♦ ● CMV IgG
†CA 125II , CA 19-9 and CA 15-3 are trademarks of Fujirebio Diagnostics, Inc. ♦ ● Progesterone
‡Limited distribution.
♦* ●* CMV IgM
♦ ● Prolactin
§This test has not been FDA cleared or approved. This test has been authorized ♦ ● Herpes-1 IgG
♦* ●* sFLT-1
by FDA under an EUA for use by authorized laboratories. This test has been ♦ ● Herpes-2 IgG
♦ ● SHBG
authorized only for detecting the presence of antibodies against SARS-CoV-2, ♦ ● Rubella IgG II
♦ ● Testosterone II
not for any other viruses or pathogens. This test is only authorized for the ♦ ● Rubella IgM
duration of the declaration that circumstances exist justifying the authorization ♦ ● Toxoplasma IgG
of emergency use of in vitro diagnostics for detection and/or diagnosis of ♦ ● Toxoplasma IgM
COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1),
unless the authorization is terminated or revoked sooner. Product availability
may vary by country. For use outside
**This test has not been reviewed by the FDA. In the US, use of this test is limited
to laboratories that are certified under Clinical Laboratory Improvement the U.S. only
Amendments of 1988 (CLIA) to perform high-complexity testing. Product
availability may vary by country and is subject to regulatory requirements.

ADVIA Centaur, ELF, and all associated marks are trademarks of Siemens
Healthcare Diagnostics Inc., or its affiliates. All other trademarks and brands
are the property of their respective owners.

Product availability may vary from country to country and is subject to

varying regulatory requirements. Please contact your local representative
for availability.

Siemens Healthineers Headquarters Published by

Siemens Healthcare GmbH Siemens Healthcare Diagnostics Inc.
Henkestr. 127 Laboratory Diagnostics
91052 Erlangen, Germany 511 Benedict Avenue
Phone: +49 9131 84-0 Tarrytown, NY 10591-5005
siemens-healthineers.com USA
Phone: +1 914-631-8000

Published by Siemens Healthcare Diagnostics Inc. · Order No. 30-21-DX-764-76 · 05-2021 · © Siemens Healthcare Diagnostics Inc., 2021